{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:23:33Z","timestamp":1793751813183,"version":"4.6.1"},"reference-count":254,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Long- and post-COVID-19 syndromes have emerged as a significant global health challenge, with millions of individuals experiencing persistent or the development of new symptoms after a long period of an initial SARS-CoV-2 infection. These symptoms are multisystemic and may indicate changes in the respiratory, neurological, cardiovascular and gastrointestinal systems, in addition to prolonged fatigue. Vaccination has played a crucial role in reducing severe disease and mortality, but the impact of the different vaccine combinations on the development and resolution of Long COVID remains a topic of debate. This review synthesizes current evidence on how different vaccine platforms, dosing strategies and booster doses influence the immunological response, protection, incidence, severity, and persistence of Long COVID symptoms. We discuss key immunological mechanisms by which vaccination may modulate and protect post-COVID syndrome outcomes, including its effects on viral clearance, immune response reprogramming, inflammation, and autoimmunity, seeking to combat misinformation and concepts spread by fake news. The review also highlights controversies and research gaps, such as variability in vaccine response among different populations and the role in the selection of more transmissible and virulent SARS-CoV-2 variants, as well as the potential differences between vaccine-induced and infection-induced immunity, and the role of pre-existing immune conditions in this scenario.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1686572","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T05:18:19Z","timestamp":1763529499000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Vaccination and COVID-19: impact on long-COVID"],"prefix":"10.3389","volume":"16","author":[{"given":"Gustavo N.","family":"Guimar\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia S.","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieila G.","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luiz","family":"Proenca-Modena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro S.","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019","volume":"82","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"B5","unstructured":"Coronavirus disease 2019 (COVID-19) Situation Report \u201351\n          \n          \n          \n          2025"},{"key":"B6","unstructured":"COVID-19 Weekly Epidemiological Update - Data as received by WHO from national authorities, as of 6 December 2020, 10 am CET\n          \n          \n          \n          2025"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30208","article-title":"Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies","volume":"10","author":"Faraji","year":"2024","journal-title":"Heliyon"},{"key":"B8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40794-022-00176-4","article-title":"Vaccines platforms and COVID-19: what you need to know","volume":"8","author":"Acosta-Coley","year":"2022","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00720-9","article-title":"COVID-19 vaccines: where we stand and challenges ahead","volume":"28","author":"Forni","year":"2021","journal-title":"Cell Death Differ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00497-5","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-coV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.1038\/s41467-024-52194-9","article-title":"Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates","volume":"15","author":"Cromer","year":"2024","journal-title":"Nat Commun"},{"key":"B15","unstructured":"FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants\n          \n          \n          \n          2023"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00896-0","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1117464","article-title":"Long COVID: a review and proposed visualization of the complexity of long COVID","volume":"14","author":"Perumal","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb2408466","article-title":"National academies of sciences, engineering, and medicine committee on examining the working definition for long covid","volume":"391","author":"Ely","year":"2024","journal-title":"Long Covid Defined. N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat Med"},{"key":"B20","unstructured":"Post COVID-19 Condition (Long COVID)\n          \n          \n          \n          2025"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00948-9","article-title":"The immunology of long COVID","volume":"23","author":"Altmann","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s43856-025-00829-3","article-title":"Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-na\u00efve individuals with Long COVID","volume":"5","author":"Grady","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e84790","DOI":"10.7554\/eLife.84790","article-title":"SARS-CoV-2 uses CD4 to infect T helper lymphocytes","volume":"12","author":"Brunetti","year":"2023","journal-title":"Elife"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(01)00255-2","article-title":"Virus infections: escape, resistance, and counterattack","volume":"15","author":"Xu","year":"2001","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02370-6","article-title":"Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development","volume":"21","author":"Ghasemiyeh","year":"2024","journal-title":"Virol J"},{"key":"B26","article-title":"Does COVID-19 vaccination reduce the risk and duration of post-COVID-19 condition","volume-title":"Rapid systematic literature review","year":"2025"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101624","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review","volume":"53","author":"Notarte","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26234","article-title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J Med Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0012822","DOI":"10.1128\/jvi.00745-22","article-title":"Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity","volume":"96","author":"Essalmani","year":"2022","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30252-X","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-coV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/JME-21-0282","article-title":"Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2","volume":"69","author":"Rangu","year":"2022","journal-title":"J Mol Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076253","article-title":"Receptors and cofactors that contribute to SARS-CoV-2 entry: can skin be an alternative route of entry","volume":"24","author":"Barthe","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e2200960119","DOI":"10.1073\/pnas.2200960119","article-title":"Morphological, cellular, and molecular basis of brain infection in COVID-19 patients","volume":"119","author":"Crunfli","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0230822","DOI":"10.1128\/mbio.02308-22","article-title":"Neuropilin-1 mediates SARS-CoV-2 infection of astrocytes in brain organoids, inducing inflammation leading to dysfunction and death of neurons","volume":"13","author":"Kong","year":"2022","journal-title":"mBio"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjac021","article-title":"SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients","volume":"14","author":"Pontelli","year":"2022","journal-title":"J Mol Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41392-022-00919-x","article-title":"ACE2-independent infection of T lymphocytes by SARS-CoV-2","volume":"7","author":"Shen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05738-11","article-title":"Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion","volume":"86","author":"Jensen","year":"2012","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.10.002","article-title":"Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit","volume":"100","author":"Zinzula","year":"2013","journal-title":"Antiviral Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00251","article-title":"Visualization of double-stranded RNA colocalizing with pattern recognition receptors in arenavirus infected cells","volume":"8","author":"Mateer","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.843342","article-title":"Depletion and dysfunction of dendritic cells: understanding SARS-CoV-2 infection","volume":"13","author":"Chang","year":"2022","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.015","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tim.2024.07.001","article-title":"Toll-like receptor 4 - a multifunctional virus recognition receptor","volume":"33","author":"Gerber-Tichet","year":"2025","journal-title":"Trends Microbiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediators Inflamm"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112189","article-title":"SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice","volume":"42","author":"Fontes-Dantas","year":"2023","journal-title":"Cell Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660019","article-title":"Infection and immune memory: variables in robust protection by vaccines against SARS-CoV-2","volume":"12","author":"Ahluwalia","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.05.002","article-title":"Long-lived effector\/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients","volume":"120","author":"Yang","year":"2006","journal-title":"Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01248-5","article-title":"The humoral response and antibodies against SARS-CoV-2 infection","volume":"23","author":"Qi","year":"2022","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00332","article-title":"Antibody-dependent cellular phagocytosis in antiviral immune responses","volume":"10","author":"Tay","year":"2019","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41392-021-00759-1","article-title":"Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e74489","DOI":"10.7554\/eLife.74489","article-title":"SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies","volume":"11","author":"Fielding","year":"2022","journal-title":"Elife"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e170681","DOI":"10.1172\/jci.insight.170681","article-title":"Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2","volume":"8","author":"Grant","year":"2023","journal-title":"JCI Insight"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e150319","DOI":"10.1172\/JCI154834","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine","volume":"131","author":"Beharier","year":"2021","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ajog.2021.03.023","article-title":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study","volume":"225","author":"Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"eabk0894","DOI":"10.1126\/sciimmunol.abk0894","article-title":"Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue","volume":"6","author":"Niessl","year":"2021","journal-title":"Sci Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1033364","article-title":"SARS-CoV-2 infected children form early immune memory responses dominated by nucleocapsid-specific CD8+ T cells and antibodies","volume":"13","author":"Lima","year":"2022","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1079-x","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8+ T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100354","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1494432","article-title":"Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity","volume":"15","author":"Belik","year":"2024","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1042\/BST20231119","article-title":"The art of hijacking: how Nsp1 impacts host gene expression during coronaviral infections","volume":"52","author":"Karousis","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-00533-x","article-title":"SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation","volume":"27","author":"Schubert","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e2101161118","DOI":"10.1073\/pnas.2101161118","article-title":"Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein","volume":"118","author":"Hsu","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e2100170118","DOI":"10.1073\/pnas.2100170118","article-title":"2\u2019-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography","volume":"118","author":"Wilamowski","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07817-y","article-title":"Molecular architecture of coronavirus double-membrane vesicle pore complex","volume":"633","author":"Huang","year":"2024","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41467-023-36140-9","article-title":"Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2","volume":"14","author":"Venet","year":"2023","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e2200413119","DOI":"10.1073\/pnas.2200413119","article-title":"The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies","volume":"119","author":"Manry","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","article-title":"Loss of bcl-6-expressing T follicular helper cells and germinal centers in COVID-19","volume":"183","author":"Kaneko","year":"2020","journal-title":"Cell"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20076","article-title":"SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses","volume":"9","author":"Wellington","year":"2023","journal-title":"Heliyon"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-coV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.06.003","article-title":"Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: A systematic review and meta-analysis","volume":"95","author":"Tariq","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1498445","article-title":"COVID-19 clinical presentation, management, and epidemiology: a concise compendium","volume":"13","author":"Maison","year":"2025","journal-title":"Front Public Health"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e140329","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S0140-6736(20)31526-9","article-title":"An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19","volume":"396","author":"Shaigany","year":"2020","journal-title":"Lancet"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08697-6","article-title":"TGF\u03b2 links EBV to multisystem inflammatory syndrome in children","volume":"640","author":"Goetzke","year":"2025","journal-title":"Nature"},{"key":"B103","unstructured":"Post COVID-19 conditions\n          \n          \n          \n          2025"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1038\/s41467-023-40012-7","article-title":"Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID","volume":"14","author":"Woodruff","year":"2023","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1101\/2023.07.27.23293177v1","article-title":"Multimodal molecular imaging reveals tissue-based T cell activation and viral RNA persistence for up to 2 years following COVID-19","author":"Peluso","year":"2023","journal-title":"medRxiv"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad199","article-title":"Unmasking the tissue-resident eukaryotic DNA virome in humans","volume":"51","author":"Py\u00f6ri\u00e4","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","article-title":"A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model","volume":"183","author":"Kreye","year":"2020","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","first-page":"26","DOI":"10.33696\/immunology.7.219","article-title":"The long-COVID syndrome: neoantigens as driving force for the onset of autoimmune diseases","volume":"7","author":"Marschalek","year":"2025","journal-title":"J Cell Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2200970","DOI":"10.1183\/13993003.00970-2022","article-title":"Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms","volume":"61","author":"Son","year":"2023","journal-title":"Eur Respir J"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146746","article-title":"Functional autoantibodies targeting G-protein-coupled receptors and their clinical phenotype in patients with long-COVID","volume":"26","author":"Hofmann","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00411-6","article-title":"Autoantibodies in long COVID: a systematic review","author":"Wilhelm","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/life12060901","article-title":"Self-reported long COVID in the general population: sociodemographic and health correlates in a cross-national sample","volume":"12","author":"Bonsaksen","year":"2022","journal-title":"Life (Basel)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319450","article-title":"Corneal confocal microscopy identifies corneal nerve fiber loss and increased dendritic cells in patients with long COVID","volume":"106","author":"Bitirgen","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.239025","article-title":"Abnormalities detected with hyperpolarized 129Xe MRI in patients with long COVID","volume":"305","author":"Grist","year":"2022","journal-title":"Radiology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02100-w","article-title":"Genome-wide association study of long COVID","volume":"57","author":"Lammi","year":"2025","journal-title":"Nat Genet"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1450853","article-title":"A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals","volume":"15","author":"Missailidis","year":"2024","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1502937","article-title":"Identification of an immunological signature of long COVID syndrome","volume":"15","author":"Guerrera","year":"2025","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41590-025-02135-5","article-title":"Identification of soluble biomarkers that associate with distinct manifestations of long COVID","volume":"26","author":"Gao","year":"2025","journal-title":"Nat Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1085988","article-title":"Biomarkers in long COVID-19: A systematic review","volume":"10","author":"Lai","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-025-02612-x","article-title":"Possible long COVID biomarker: identification of SARS-CoV-2 related protein(s) in Serum Extracellular Vesicles","author":"Abbasi","year":"2025","journal-title":"Infection"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103358","article-title":"Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomized phase IIa clinical trial (RCT)","volume":"86","author":"Hohberger","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.0461","article-title":"One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study","volume":"79","author":"Liu","year":"2022","journal-title":"JAMA Neurol"},{"key":"B128","unstructured":"Prevalence of post COVID-19 condition symptoms: a systematic review and meta-analysis of cohort study data, stratified by recruitment setting\n          \n          \n          \n          2022"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2025.101026","article-title":"Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group","volume":"44","author":"Gottlieb","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00941-2","article-title":"Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2","volume":"399","author":"Antonelli","year":"2022","journal-title":"Lancet"},{"key":"B132","unstructured":"Self-reported long COVID after infection with the Omicron variant in the UK - Office for National Statistics\n          \n          \n            \n              Ayoubkhani\n              D\n            \n            \n              Bosworth\n              M\n            \n          \n          UK Office for National Statistics\n          \n          2022"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31821-3","article-title":"COVID-19 vaccine trials should seek worthwhile efficacy","volume":"396","author":"Krause","year":"2020","journal-title":"Lancet"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B136","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-45024-6","volume-title":"Vaccine Analysis: Strategies, Principles, and Control","author":"Nunnally","year":"2015"},{"key":"B137","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomized, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B138","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B139","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomized, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032411","article-title":"Humoral and cellular immune responses to CoronaVac up to one year after vaccination","volume":"13","author":"Costa","year":"2022","journal-title":"Front Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines2030624","article-title":"Developments in viral vector-based vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23546","article-title":"Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults","volume":"85","author":"Zhang","year":"2013","journal-title":"J Med Virol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31687-1","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomized controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"B146","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/imr.13088","article-title":"Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine","volume":"310","author":"Le Gars","year":"2022","journal-title":"Immunol Rev"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117608","article-title":"Final analysis of efficacy and safety of single-dose ad26","volume":"386","author":"Sadoff","year":"2022","journal-title":"COV2.S. N Engl J Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01363-0","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32720-3","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol Ther"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00987-2","article-title":"Immunogenicity of mRNA-1273 and BNT162b2 in immunocompromised patients: systematic review and meta-analysis using GRADE","volume":"13","author":"Kavikondala","year":"2024","journal-title":"Infect Dis Ther"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030243","article-title":"Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2\/COVID-19","volume":"9","author":"G\u00f3mez","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nat Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109415","article-title":"SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination","volume":"36","author":"Hoffmann","year":"2021","journal-title":"Cell Rep"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02876-2","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/v15010167","article-title":"A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies","volume":"15","author":"Chatterjee","year":"2023","journal-title":"Viruses"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03657-2","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v14.i3.89761","article-title":"COVID-19 mutations: An overview","volume":"14","author":"Sarkar","year":"2024","journal-title":"World J Methodol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2023.108540","article-title":"Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant","volume":"124","author":"Wang","year":"2023","journal-title":"J Mol Graph Model"},{"key":"B170","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 Omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.2023329","article-title":"SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells","volume":"11","author":"Zhao","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01241-6","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett","year":"2022","journal-title":"Nat Microbiol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"19858","DOI":"10.1038\/s41598-022-22552-y","article-title":"Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations","volume":"12","author":"Jacobsen","year":"2022","journal-title":"Sci Rep"},{"key":"B175","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41541-023-00633-x","article-title":"Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2","volume":"8","author":"Swart","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e29416","DOI":"10.1002\/jmv.29416","article-title":"Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future","volume":"96","author":"Souza","year":"2024","journal-title":"J Med Virol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02092-8","article-title":"Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA","volume":"29","author":"Scheaffer","year":"2023","journal-title":"5 Omicron variant mice. Nat Med"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2023.107042","article-title":"Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy","volume":"248","author":"Trombetta","year":"2023","journal-title":"Acta Trop"},{"key":"B179","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1038\/s41467-022-30340-5","article-title":"Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant","volume":"13","author":"Zuo","year":"2022","journal-title":"Nat Commun"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00129-4","article-title":"Neutralization of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study","volume":"2","author":"Souza","year":"2021","journal-title":"Lancet Microbe"},{"key":"B181","doi-asserted-by":"publisher","first-page":"eabj1750","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees","volume":"6","author":"Geers","year":"2021","journal-title":"Sci Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100355","article-title":"Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"key":"B183","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"B185","doi-asserted-by":"publisher","first-page":"e2022179","DOI":"10.23750\/abm.v93i1.12210","article-title":"Delta variant: the new challenge of COVID-19 pandemic, an overview of epidemiological, clinical, and immune characteristics","volume":"93","author":"Samieefar","year":"2022","journal-title":"Acta Biomed"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3390\/idr13040084","article-title":"COVID-19 vaccine booster: to boost or not to boost","volume":"13","author":"Shekhar","year":"2021","journal-title":"Infect Dis Rep"},{"key":"B187","unstructured":"Pfizer and BioNTech granted FDA Emergency Use Authorization of Omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine booster for ages 12 years and older [press release]\n          \n          \n          \n          2022"},{"key":"B188","unstructured":"Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers (Original and Omicron BA.4\/BA.5 Bivalent) [fact sheet]\n          \n          \n          \n          2022"},{"key":"B189","unstructured":"FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants [press release]\n          \n          \n          \n          2024"},{"key":"B190","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12979-024-00466-9","article-title":"Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults","volume":"21","author":"Gelderloos","year":"2024","journal-title":"Immun Ageing"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106317","article-title":"Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines","volume":"89","author":"Marchese","year":"2024","journal-title":"J Infect"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3390\/v15061370","article-title":"Do COVID-19 vaccinations affect the most common post-COVID symptoms? Initial data from the STOP-COVID register-12-month follow-up","volume":"15","author":"Babicki","year":"2023","journal-title":"Viruses"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051915","article-title":"The very long COVID: persistence of symptoms after 12\u201318 months from the onset of infection and hospitalization","volume":"12","author":"Ranucci","year":"2023","journal-title":"J Clin Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.11.009","article-title":"Post-acute symptoms 3\u201315 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection","volume":"126","author":"Brunvoll","year":"2023","journal-title":"Int J Infect Dis"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101961","article-title":"Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study","volume":"59","author":"Morello","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147549","article-title":"Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection","volume":"14","author":"Antar","year":"2023","journal-title":"Front Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41467-023-44090-5","article-title":"Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study","volume":"15","author":"Ozonoff","year":"2024","journal-title":"Nat Commun"},{"key":"B198","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/s41467-024-51893-7","article-title":"Early biological markers of post-acute sequelae of SARS-CoV-2 infection","volume":"15","author":"Lu","year":"2024","journal-title":"Nat Commun"},{"key":"B199","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/cid\/ciae539","article-title":"Relationship between acute SARS-CoV-2 viral clearance and long COVID-19 (Long COVID) symptoms: A cohort study","volume":"80","author":"Herbert","year":"2025","journal-title":"Clin Infect Dis"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100663","article-title":"The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep Med"},{"key":"B202","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12985-021-01680-3","article-title":"Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection","volume":"18","author":"Hamzeh-Cognasse","year":"2021","journal-title":"Virol J"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107842","article-title":"Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses","volume":"136","author":"Nayyerabadi","year":"2023","journal-title":"Int J Infect Dis"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403211","article-title":"Postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras","volume":"391","author":"Xie","year":"2024","journal-title":"N Engl J Med"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01646-3","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat Immunol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00240-X","article-title":"Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19","volume":"9","author":"Ceulemans","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324280","article-title":"Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19","volume":"71","author":"Cheung","year":"2022","journal-title":"Gut"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.939989","article-title":"Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID","volume":"13","author":"Goh","year":"2022","journal-title":"Front Immunol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746021","article-title":"Persistence of SARS CoV-2 S1 protein in CD16+ Monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection","volume":"12","author":"Patterson","year":"2022","journal-title":"Front Immunol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.chom.2024.11.007","article-title":"Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19","volume":"32","author":"Rong","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104587","article-title":"Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4\/MD-2 complex","volume":"85","author":"Bhattacharya","year":"2020","journal-title":"Infect Genet Evol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J Med Virol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"e28568","DOI":"10.1002\/jmv.28568","article-title":"Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19","volume":"95","author":"Craddock","year":"2023","journal-title":"J Med Virol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjac058","article-title":"SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade","volume":"14","author":"Samsudin","year":"2023","journal-title":"J Mol Cell Biol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00115-5","article-title":"Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies","volume":"4","author":"Buonsenso","year":"2023","journal-title":"Lancet Microbe"},{"key":"B217","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2023.08.019","article-title":"Association between virus variants, vaccination, previous infections, and post-COVID-19 risk","volume":"136","author":"Diexer","year":"2023","journal-title":"Int J Infect Dis"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101218","article-title":"Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants","volume":"52","author":"Qin","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"B219","doi-asserted-by":"publisher","first-page":"e000385","DOI":"10.1136\/bmjmed-2022-000385","article-title":"Effect of covid-19 vaccination on long covid: systematic review","volume":"2","author":"Byambasuren","year":"2023","journal-title":"BMJ Med"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B222","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s44161-023-00336-5","article-title":"SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels","volume":"2","author":"Eberhardt","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41467-023-36686-8","article-title":"SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity","volume":"14","author":"Jaycox","year":"2023","journal-title":"Nat Commun"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02288-9","article-title":"Long-term symptoms after SARS-CoV-2 infection in a cohort of people living with HIV","volume":"52","author":"Degli Antoni","year":"2024","journal-title":"Infection"},{"key":"B225","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10875-024-01656-2","article-title":"High prevalence of long COVID in common variable immunodeficiency: an italian multicentric study","volume":"44","author":"Villa","year":"2024","journal-title":"J Clin Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00414-9","article-title":"The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia","volume":"12","author":"Catal\u00e0","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B227","doi-asserted-by":"publisher","first-page":"e2224359","DOI":"10.1001\/jamanetworkopen.2022.24359","article-title":"Rates and factors associated with documentation of diagnostic codes for long COVID in the national veterans affairs health care system","volume":"5","author":"Ioannou","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2022.04.013","article-title":"Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections","volume":"103","author":"Taquet","year":"2022","journal-title":"Brain Behav Immun"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050652","article-title":"The impact of COVID vaccination on symptoms of long COVID: an international survey of people with lived experience of long COVID","volume":"10","author":"Strain","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729251","article-title":"COVID-19 vaccine-related thrombosis: A systematic review and exploratory analysis","volume":"12","author":"Bilotta","year":"2021","journal-title":"Front Immunol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040393","article-title":"Analysis of thrombotic adverse reactions of COVID-19 astraZeneca vaccine reported to eudraVigilance database","volume":"9","author":"Tobaiqy","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167879","article-title":"Do long COVID and COVID vaccine side effects share pathophysiological picture and biochemical pathways","volume":"26","author":"Lesgards","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B234","doi-asserted-by":"publisher","first-page":"e076990","DOI":"10.1136\/bmj-2023-076990","article-title":"Covid-19 vaccine effectiveness against post-covid-19 condition among 589\u2009722 individuals in Sweden: population based cohort study","volume":"383","author":"Lundberg-Morris","year":"2023","journal-title":"BMJ"},{"key":"B235","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1017\/ash.2023.447","article-title":"The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research","volume":"3","author":"Marra","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27689","article-title":"Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID","volume":"94","author":"Tsuchida","year":"2022","journal-title":"J Med Virol"},{"key":"B237","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12969-025-01093-4","article-title":"Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a pediatric population: a comprehensive analysis","volume":"23","author":"Freiberg","year":"2025","journal-title":"Pediatr Rheumatol Online J"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3390\/children10101598","article-title":"Atopy and elevation of igE, igG3, and igG4 may be risk factors for post COVID-19 condition in children and adolescents","volume":"10","author":"K\u00f6rner","year":"2023","journal-title":"Children (Basel)"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J Infect Dis"},{"key":"B241","doi-asserted-by":"publisher","first-page":"228ra38","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Transl Med"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1020844","article-title":"mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine","volume":"13","author":"Buhre","year":"2023","journal-title":"Front Immunol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"eade2798","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci Immunol"},{"key":"B244","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1017\/S0950268824001687","article-title":"Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study","volume":"152","author":"Zheng","year":"2024","journal-title":"Epidemiol Infect"},{"key":"B245","doi-asserted-by":"publisher","first-page":"e2430983","DOI":"10.1001\/jamanetworkopen.2024.30983","article-title":"Autoimmune sequelae after delta or omicron variant SARS-CoV-2 infection in a highly vaccinated cohort","volume":"7","author":"Wee","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B246","unstructured":"UKHSA Review Shows Vaccinated Less Likely to Have Long COVID than Unvaccinated\n          \n          \n          \n          2022"},{"key":"B247","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annepidem.2024.02.007","article-title":"The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020-2022","volume":"92","author":"MacCallum-Bridges","year":"2024","journal-title":"Ann Epidemiol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"B251","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programs: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050798","article-title":"Immunogenicity and safety of homologous and heterologous prime-boost immunization with COVID-19 vaccine: systematic review and meta-analysis","volume":"10","author":"Cheng","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.02.005","article-title":"Autoimmunity in long COVID","volume":"155","author":"Talwar","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2215780","article-title":"Bivalent covid-19 vaccines - A cautionary tale","volume":"388","author":"Offit","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1686572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T05:18:24Z","timestamp":1763529504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1686572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":254,"alternative-id":["10.3389\/fimmu.2025.1686572"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1686572","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"1686572"}}